AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
17 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
16 Feb 2012 07:00 AM
RNS
Director Declaration
16 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
15 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
14 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
13 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
10 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
09 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
08 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
07 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
06 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
03 Feb 2012 04:30 PM
RNS
Holding(s) in Company
03 Feb 2012 03:30 PM
RNS
Director/PDMR Shareholding
03 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
02 Feb 2012 01:00 PM
RNS
Share Repurchase Programme
02 Feb 2012 07:05 AM
RNS
Transaction in Own Shares
02 Feb 2012 07:01 AM
RNS
Final Results - Part 3 of 3
02 Feb 2012 07:00 AM
RNS
Final Results - Part 2 of 3
02 Feb 2012 07:00 AM
RNS
Final Results - Part 1 of 3
01 Feb 2012 04:00 PM
RNS
Total Voting Rights
01 Feb 2012 09:00 AM
RNS
Notice of Results
01 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
31 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
30 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
27 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
26 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
25 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
24 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
23 Jan 2012 07:01 AM
RNS
Transaction in Own Shares
20 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
19 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
19 Jan 2012 07:00 AM
RNS
FDA COMPLETE RESPONSE LETTER FOR DAPAGLIFLOZIN
18 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
16 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
13 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
12 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
11 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
10 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
09 Jan 2012 07:00 AM
RNS
Reaffirms financial guidance for 2011
09 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
06 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
05 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
04 Jan 2012 11:03 AM
RNS
Director/PDMR Shareholding
04 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
03 Jan 2012 04:00 PM
RNS
Total Voting Rights
29 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
23 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
22 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
21 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
20 Dec 2011 07:00 AM
RNS
UPDATES ON OLAPARIB AND TC-5214 PROGRAMMES

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings